期刊文献+

联合维生素E和维生素C对维持性血液透析患者脂联素和氧化应激的影响 被引量:3

下载PDF
导出
摘要 【目的】研究联合维生素E(VitE)和和维生素C(VitC)对维持性血液透析(MDH)患者脂联素(ADPN)和氧化应激的影响。【方法】MHD患者64例,分为对照组(C组)和联合治疗组(T组,给予VitE200mg/d和VitC200mg/d口服,治疗3个月),并以正常人20例为正常对照组(N组)。比较三组各项临床指标。【结果】与N组比较,MHD患者血清丙二醛(MDA)水平升高,谷胱甘肽过氧化物酶(GSHPx)、超氧化物歧化酶(SOD)水平降低;同时ADPN升高。给予VitE和VitC治疗后,患者血清MDA水平降低,GSH—Px、SOD水平升高,同时ADPN进一步升高,ADPN与GSHPx、SOD呈正相关,与MDA呈负相关。【结论】口服VitE和VitC可能通过抑制MHD患者体内氧化应激状态,上调ADPN的水平,发挥心血管保护作用。
出处 《医学临床研究》 CAS 2010年第8期1507-1508,共2页 Journal of Clinical Research
  • 相关文献

参考文献8

  • 1Kalantar-Zadeh K, Block G, Humphreys MH. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients[J]. Kidney Int , 2003, 63, 793-808.
  • 2UsbertiM, Gerardi GM, Gazzotti RM, et al. Oxidative stress and cardiovascular disease in dialyzed patients[J].Nephron , 2002, 91(1) :25-33.
  • 3Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors[J]. Endocrine Reviews , 2005, 26 (3) .439-451 .
  • 4Vivekananthan DP,Penn MS,Sapp SK, at al . Use of antioxidant vitamins for the prevention of cardiovascular disease[J].Lancet ,2003, 361:2017-2023.
  • 5梁敏,侯凡凡,田建伟,刘俊,张国华,林跃萍,魏冬梅,陈瑗.终末期肾病氧化应激状态的研究[J].解放军医学杂志,2003,28(6):540-541. 被引量:15
  • 6王东红.脂联素与慢性肾功能不全[J].国外医学(老年医学分册),2009,30(6):269-272. 被引量:1
  • 7Ciocouu M, Badescu M, Paduraru I. Protecting antioxiclative effects of vitamins E and C in experimental physical stress[J]. J Physiol Biochem , 2007 ,63 (3) :1872-1941.
  • 8冯利平,张玲,钟玲,朱冬菊,刘玲.维生素E对维持性血液透析患者氧化应激及微炎症状态的影响[J].中国实用内科杂志,2007,27(3):215-217. 被引量:16

二级参考文献36

  • 1齐凤菊,周玫,孔华,陈瑗.血浆、红细胞和组织中硒谷胱甘肽过氧酶的测定方法及健康成人的测定值[J].第一军医大学学报,1989,9(3):241-244. 被引量:13
  • 2吴红赤,凌红,那士平,解汝娟.白细胞介素10基因启动子-1082A/G多态性与终末期肾病患者微炎症和动脉硬化的关系[J].中华医学杂志,2005,85(29):2076-2080. 被引量:10
  • 3Adamczak M, Czerwienska B, Chudek J et al. Renal extraction of circulating adiponectin in patients with rcnovascular hypertensiun. Acta Physiol Hung, 2007; 94 (1-2): 143 - 148.
  • 4Yaturu S, Reddy RD, Rains Jet al. Plasma and urine levels of resistin and adiponectin in chronic kidney disease. Cytokine, 2007; 37 (1): 1-5.
  • 5Ohashi K, lwatani H, Kihara Set al. Exacerbation of albuminuria and renal fibrosis in subtotal renal ablation model of adiponectin - knockout mice. Arterioscler Thromb Vasc Biol, 2007; 27 (9): 1910-1917.
  • 6Guebre -Egziabher F, Drai J, Fouque D et al. Adiponectin and chronic kidney disease. J Ren Nutr, 2007; 17 (1): 9-12.
  • 7Kollcrits B, Fliser D, Heid IN et al. Gender - specific association of adiponeetin as a predictor of progression of chronic kidney disease: the Mild to Moderate Kidney Disease Study. Kidney Int, 2007; 71 (12) : 1279-1286.
  • 8Yilmaz MI, Saglam M, Qureshi AR et al. Endothelial dysfunction in type - 2 diabetics with early diabetic nephropathy is associated with low circulating adiponectin. Nephrol Dial Transplant, 2008 ; 23 (3) : 959 - 965.
  • 9Mitsnefes M, Kartal J, Khoury P et al. Adiponectin in children with chronic kidney disease: role of adiposity and kidney dysfunction. Clin J Am Soc Nephrol, 2007; 2 (1) : 46-50.
  • 10Barazzoni R, Bemardi A, Biasia F et al. Low fat adiponectin expression is associated with oxidative stress in nondiabetic humans with chronic kidney disease - impact on plasma adiponectin concentration. Am J Physiol Regul Integr Comp Physiol, 2007 ; 293 ( 1 ) : R47 - 54.

共引文献29

同被引文献18

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部